Follow by Email


Caraco Pharmaceutical Laboratories on Tuesday said it has entered into a merger agreement with Sun Pharmaceutical Industries, which has increased its offer price per share by 10.52%.

"The merger agreement provides that all shareholders of Caraco, other than Sun Pharma and Sun Global, will receive a cash payment of $5.25 per share upon the closing of the transaction," Caraco said in a statement on its website.

The company had earlier announced that Sun Pharma and Sun Global had proposed to delist the NYSE listed firm, under which Sun Pharma, Sun Global and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock for a per share consideration of $4.75 cash.

Sun Pharma and its subsidiary Sun Global collectively own 75.8% of Caraco common stock.

"Upon completion of the transaction, Caraco will become a privately held company and its common stock will no longer be traded on the NYSE Amex," it said.


Post a Comment

please leave your opinion about his blog ,
this will help us to give some more quality information.

Write 4 namesake-expert

Thank you for your interest in being part of the namesake-expert writing community.
namesake-expert publishes original news content, opinion pieces, trending topics and breaking stories in the area of technology, entertainment, business, politics, lifestyle, videos,sports, lifestyle and women’s issues. Articles must be written in English, published first on namesake-expert and will be reviewed by the “seasoned” namesake-expert Team.
If you are interested revert back to

side l


images in posts are not related to the content .
it pasted to relate the content or to describe the message of post.
if any photo of any person in post hurting any sentiment it can be removed busted. pls complain it to this Email -->